Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Vilastobart+Retifanlimab in BRCA or PALB2 Deficient PC

Massachusetts General Hospital · 2027
ClinicalTrials.gov · Datasets · License: Public Domain · 2027
Open Source ↗
pancreatic cancer metastatic, brca1, brca2, or palb2 mutation, metastatic pancreatic cancer, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 828491
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.